Evidence map›Paper›PMID 35546163›Full record

ArticleScientific reports2022

Expanding the use of ethanol as a feedstock for cell-free synthetic biochemistry by implementing acetyl-CoA and ATP generating pathways.

Hongjiang Liu, Mark A Arbing, James U Bowie

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Cell-Free Production and Regeneration of Cofactors.Advances in biochemical engineering/biotechnology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hongjiang LiuDepartment of Chemistry and Biochemistry, Molecular Biology Institute, UCLA-DOE Institute of Genomics and Proteomics, University of California Los Angeles, Boyer Hall, 611 Charles E. Young Dr. E, Los Angeles, CA, 90095-1570, USA.
Mark A ArbingDepartment of Chemistry and Biochemistry, Molecular Biology Institute, UCLA-DOE Institute of Genomics and Proteomics, University of California Los Angeles, Boyer Hall, 611 Charles E. Young Dr. E, Los Angeles, CA, 90095-1570, USA.
James U BowieDepartment of Chemistry and Biochemistry, Molecular Biology Institute, UCLA-DOE Institute of Genomics and Proteomics, University of California Los Angeles, Boyer Hall, 611 Charles E. Young Dr. E, Los Angeles, CA, 90095-1570, USA. bowie@mbi.ucla.edu.
University of California, Los Angeles · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ethanol is a widely available carbon compound that can be increasingly produced with a net negative carbon balance. Carbon-negative ethanol might therefore provide a feedstock for building a wider range of sustainable chemicals. Here we show how ethanol can be converted with a cell free system into acetyl-CoA, a central precursor for myriad biochemicals, and how we can use the energy stored in ethanol to generate ATP, another key molecule important for powering biochemical pathways. The ATP generator produces acetone as a value-added side product. Our ATP generator reached titers of 27 ± 6 mM ATP and 59 ± 15 mM acetone with maximum ATP synthesis rate of 2.8 ± 0.6 mM/h and acetone of 7.8 ± 0.8 mM/h. We illustrated how the ATP generating module can power cell-free biochemical pathways by converting mevalonate into isoprenol at a titer of 12.5 ± 0.8 mM and a maximum productivity of 1.0 ± 0.05 mM/h. These proof-of-principle demonstrations may ultimately find their way to the manufacture of diverse chemicals from ethanol and other simple carbon compounds.

Indexed as

EthanolMetabolic EngineeringAcetoneAcetyl Coenzyme AAdenosine TriphosphateCarbonAcetoneAcetyl Coenzyme AAdenosine TriphosphateCarbonEthanol

Identifiers

PMID35546163
PMCPMC9095697
OpenAlexW4280494219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.